PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Mar-2022 Asia Pacific Baby Care Products Market Forecasts to 2026: Organic and Natural Segment to Play a Key Role - ResearchAndMarkets.com Businesswire
09-Mar-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Mar-2022 Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022 Businesswire
09-Mar-2022 Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022 Businesswire
09-Mar-2022 HKSTP and Infineon Launch Co-Incubation Programme to Accelerate Microelectronics Innovation and Propel Startups to Success Businesswire
09-Mar-2022 Boehringer Ingelheim and OSE Immunotherapeutics To Present Biomarker Analyses From the Phase 1 Clinical Trial With First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors Businesswire
09-Mar-2022 Onxeo’s New Preclinical Data Confirm the Relevance of Combining AsiDNA™ With PARP Inhibitors in Treating Homologous Recombination Proficient Tumors Businesswire
09-Mar-2022 ElevationSpace, a Japanese Space Start-up Company That Develops Satellites to Replace the ISS, Raises $2.7 Million of Seed-funding Businesswire
08-Mar-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cano Health, Inc. (CANO) on Behalf of Investors Businesswire
08-Mar-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of RBB Bancorp (RBB) on Behalf of Investors Businesswire
08-Mar-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Core Scientific, Inc. (CORZ) on Behalf of Investors Businesswire
08-Mar-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Grab Holdings Limited (GRAB, GRABW) on Behalf of Investors Businesswire
08-Mar-2022 Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021 Businesswire
08-Mar-2022 Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira® Businesswire
08-Mar-2022 Orum Therapeutics to Present Preclinical Data for ORM-5029, a Novel Antibody Neodegrader Conjugate, at the AACR Annual Meeting 2022 Businesswire
08-Mar-2022 SQZ Biotechnologies to Present New Enhanced APC Platform Preclinical Findings and ENVOY-001 Phase 1/2 Clinical Trial in Progress Poster at the American Association for Cancer Research 2022 Annual Meeting Businesswire
08-Mar-2022  Elephas to Show First Data on Breakthrough Oncology Diagnostics Platform at American Association for Cancer Research Businesswire
08-Mar-2022 Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results Selected for an Oral Presentation at the 2022 AACR Annual Meeting Businesswire
08-Mar-2022 GlycoMimetics to Participate at Upcoming Roth Investor Conference Businesswire
08-Mar-2022 Aura Biosciences to Present Preclinical Data Highlighting AU‑011’s Potential to Target a Broad Number of Tumor Types at the 2022 AACR Annual Meeting Businesswire